Jason A Dominitz1, Douglas J Robertson2, Dennis J Ahnen3, James E Allison4, Margaret Antonelli5, Kathy D Boardman6, Maria Ciarleglio7, Barbara J Del Curto6, Grant D Huang8, Thomas F Imperiale9, Meaghan F Larson10, David Lieberman11, Theresa O'Connor5, Timothy J O'Leary12, Peter Peduzzi7, Dawn Provenzale13, Aasma Shaukat14, Shahnaz Sultan14, Amy Voorhees15, Robert Wallace5, Peter D Guarino16. 1. VA Puget Sound Health Care System and University of Washington School of Medicine, Seattle, Washington, USA. 2. VA Medical Center, White River Junction, Vermont and Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. 3. VA Eastern Colorado Health Care System, Denver, Colorado, USA. 4. Division of Gastroenterology, Department of Medicine, University of California San Francisco, Kaiser Division of Research, San Francisco, California, USA. 5. Cooperative Studies Program Coordinating Center, VA Connecticut Healthcare System, West Haven, Connecticut, USA. 6. Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico, USA. 7. Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA. 8. Cooperative Studies Program Central Office, Office of Research and Development, Washington, DC, USA. 9. Center for Innovation, Health Services Research and Development, Richard L. Roudebush VA Medical Center and Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. 10. VA Puget Sound Health Care System, Seattle, Washington, USA. 11. Portland VA Health Care System, Portland, Oregon, USA. 12. Office of Research and Development Veterans Health Administration Washington DC and Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA. 13. VA Cooperative Studies Epidemiology Center-Durham and Duke University Medical Center, Durham, North Carolina, USA. 14. Center for Chronic Disease Outcomes Research, Minneapolis Veterans Affairs Healthcare System, Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA. 15. White River Junction VA Medical Center, White River Junction, Vermont, USA. 16. Cooperative Studies Program Coordinating Center, VA Connecticut Healthcare System, West Haven, CT and the Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Abstract
RATIONALE: Colorectal cancer (CRC) is preventable through screening, with colonoscopy and fecal occult blood testing comprising the two most commonly used screening tests. Given the differences in complexity, risk, and cost, it is important to understand these tests' comparative effectiveness. STUDY DESIGN: The CONFIRM Study is a large, pragmatic, multicenter, randomized, parallel group trial to compare screening with colonoscopy vs. the annual fecal immunochemical test (FIT) in 50,000 average risk individuals. CONFIRM examines whether screening colonoscopy will be superior to a FIT-based screening program in the prevention of CRC mortality measured over 10 years. Eligible individuals 50-75 years of age and due for CRC screening are recruited from 46 Veterans Affairs (VA) medical centers. Participants are randomized to either colonoscopy or annual FIT. Results of colonoscopy are managed as per usual care and study participants are assessed for complications. Participants testing FIT positive are referred for colonoscopy. Participants are surveyed annually to determine if they have undergone colonoscopy or been diagnosed with CRC. The primary endpoint is CRC mortality. The secondary endpoints are (1) CRC incidence (2) complications of screening colonoscopy, and (3) the association between colonoscopists' characteristics and neoplasia detection, complications and post-colonoscopy CRC. CONFIRM leverages several key characteristics of the VA's integrated healthcare system, including a shared medical record with national databases, electronic CRC screening reminders, and a robust national research infrastructure with experience in conducting large-scale clinical trials. When completed, CONFIRM will be the largest intervention trial conducted within the VA (ClinicalTrials.gov identifier: NCT01239082).
RCT Entities:
RATIONALE: Colorectal cancer (CRC) is preventable through screening, with colonoscopy and fecal occult blood testing comprising the two most commonly used screening tests. Given the differences in complexity, risk, and cost, it is important to understand these tests' comparative effectiveness. STUDY DESIGN: The CONFIRM Study is a large, pragmatic, multicenter, randomized, parallel group trial to compare screening with colonoscopy vs. the annual fecal immunochemical test (FIT) in 50,000 average risk individuals. CONFIRM examines whether screening colonoscopy will be superior to a FIT-based screening program in the prevention of CRC mortality measured over 10 years. Eligible individuals 50-75 years of age and due for CRC screening are recruited from 46 Veterans Affairs (VA) medical centers. Participants are randomized to either colonoscopy or annual FIT. Results of colonoscopy are managed as per usual care and study participants are assessed for complications. Participants testing FIT positive are referred for colonoscopy. Participants are surveyed annually to determine if they have undergone colonoscopy or been diagnosed with CRC. The primary endpoint is CRC mortality. The secondary endpoints are (1) CRC incidence (2) complications of screening colonoscopy, and (3) the association between colonoscopists' characteristics and neoplasia detection, complications and post-colonoscopy CRC. CONFIRM leverages several key characteristics of the VA's integrated healthcare system, including a shared medical record with national databases, electronic CRC screening reminders, and a robust national research infrastructure with experience in conducting large-scale clinical trials. When completed, CONFIRM will be the largest intervention trial conducted within the VA (ClinicalTrials.gov identifier: NCT01239082).
Authors: Gillian Libby; Jane Bray; Jennifer Champion; Linda A Brownlee; Janice Birrell; Dermot R Gorman; Emilia M Crighton; Callum G Fraser; Robert J C Steele Journal: J Med Screen Date: 2011 Impact factor: 2.136
Authors: Rebecca L Siegel; Kimberly D Miller; Stacey A Fedewa; Dennis J Ahnen; Reinier G S Meester; Afsaneh Barzi; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2017-03-01 Impact factor: 508.702
Authors: Charles J Kahi; David G Hewett; Dustin Lee Norton; George J Eckert; Douglas K Rex Journal: Clin Gastroenterol Hepatol Date: 2010-10-01 Impact factor: 11.382
Authors: Enrique Quintero; Antoni Castells; Luis Bujanda; Joaquín Cubiella; Dolores Salas; Ángel Lanas; Montserrat Andreu; Fernando Carballo; Juan Diego Morillas; Cristina Hernández; Rodrigo Jover; Isabel Montalvo; Juan Arenas; Eva Laredo; Vicent Hernández; Felipe Iglesias; Estela Cid; Raquel Zubizarreta; Teresa Sala; Marta Ponce; Mercedes Andrés; Gloria Teruel; Antonio Peris; María-Pilar Roncales; Mónica Polo-Tomás; Xavier Bessa; Olga Ferrer-Armengou; Jaume Grau; Anna Serradesanferm; Akiko Ono; José Cruzado; Francisco Pérez-Riquelme; Inmaculada Alonso-Abreu; Mariola de la Vega-Prieto; Juana Maria Reyes-Melian; Guillermo Cacho; José Díaz-Tasende; Alberto Herreros-de-Tejada; Carmen Poves; Cecilio Santander; Andrés González-Navarro Journal: N Engl J Med Date: 2012-02-23 Impact factor: 91.245
Authors: Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck Journal: Ann Intern Med Date: 2008-12-15 Impact factor: 25.391
Authors: Michael Bretthauer; Michal F Kaminski; Magnus Løberg; Ann G Zauber; Jaroslaw Regula; Ernst J Kuipers; Miguel A Hernán; Eleanor McFadden; Annike Sunde; Mette Kalager; Evelien Dekker; Iris Lansdorp-Vogelaar; Kjetil Garborg; Maciej Rupinski; Manon C W Spaander; Marek Bugajski; Ole Høie; Tryggvi Stefansson; Geir Hoff; Hans-Olov Adami Journal: JAMA Intern Med Date: 2016-07-01 Impact factor: 21.873
Authors: Cynthia W Ko; V Paul Doria-Rose; Michael J Barrett; Aruna Kamineni; Lindsey Enewold; Noel S Weiss Journal: Int J Colorectal Dis Date: 2019-05-31 Impact factor: 2.571
Authors: Sidney J Winawer; Ann G Zauber; Michael J O'Brien; Joseph Geenen; Jerome D Waye Journal: Gastrointest Endosc Date: 2020-09-30 Impact factor: 9.427
Authors: Rafael Cardoso; Anna Zhu; Feng Guo; Thomas Heisser; Michael Hoffmeister; Hermann Brenner Journal: Dtsch Arztebl Int Date: 2021-04-23 Impact factor: 5.594